Article
The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV)
31 May 2024
Abstract excerpt
Cervical cancer (CC) and other malignant malignancies are acknowledged to be primarily caused by persistent human papillomavirus (HPV) infection. Historically, vaccinations against viruses that produce neutralizing antibodies unique to the virus have been an affordable way to manage viral diseases. CC risk is decreased, but not eliminated, by HPV vaccinations. Since vaccinations have been made available globally,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
